News release: Interferon does not improve outcomes for hospitalized adults with COVID-19 – NIH News Releases Original study: Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial – The Lancet Respiratory Medicine  

The post RCT: Interferon does not improve outcomes for hospitalized adults with COVID-19. appeared first on Links Medicus.